NuScale Set for Merger Approval

by | Apr 8, 2022

SV / NuScale set merger vote date. A look at next week’s merger and extension votes. And the rest of the day’s news in SPACs.

————————————————-
Free Investor Resources from Boardroom Alpha
—————————————————-
** Podcast: Know Who Drives Return
** Daily SPAC Newsletter
** Full SPAC Listing

Today ends a busy week in SPACland, with two deSPACs and three DAs. Even some deal speculation is back, with onlyFans taking center stage. While regulatory pressures may slow the pace of new issues, this week proves that deals are still getting done. It’s also refreshing to see deSPACs trade with less volatility out of the gate.

deSPACs this week:

  • Gogoro (GGR)

  • MoonLake Immunotherapeutics (MLTX)
  • Mergers this week:

    • PAFO + Caravelle Group
    • ISAA /HYPEBEAST
    • RVAC / Westrock Coffee

    Spring Valley Acquisition Corp. (SV) / Sets NuScale Merger Date

    Spring Valley Acquisition Corp. (SV) Sets 4.28 date for merger approval on NuScale Power. NuScale makes advanced nuclear small modular reactor (SMR) technology. Upon closing, NuScale will trade on the NYSE as “SMR. “

    Elsewhere in SPACs

    On tap for next week is Global SPAC Partners Co. (GLSPT) extension vote. Other upcoming extension votes: GRCY, MACU, BCAC.

    Upcoming Merger and Extension Votes

    Source: Boardroom Alpha

    More from Boardroom Alpha

    For ongoing tracking, analytics, and data on SPACs checkout Boardroom Alpha’s SPAC Data and Analytics service.

    Recent Analysis

    Daily SPAC Update – Feb 6, 2024

    Daily SPAC Update for Feb 5, 2024. ARIZ, MAQC, PTWO Extension Votes. NUBI DeSPAC. ICYMI SEC’s Final SPAC Rules w/ research links.

    Daily SPAC Update – Feb 5, 2024

    Daily SPAC Update for Feb 5, 2024. ARIZ, MAQC, PTWO Extension Votes. NUBI DeSPAC. ICYMI SEC’s Final SPAC Rules w/ research links.

    Disclaimer

    The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

    This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

    None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

    No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.